Journal ArticleOPEN ACCESS

Nav1.7 withholds its pain potential

  • Kingwell K
Nature Reviews Drug Discovery (2019) 18(5) 321-323
DOI: 10.1038/d41573-019-00065-0
N/ACitations
Citations of this article
140Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Despite compelling genetic validation, drug developers are struggling to unlock the therapeutic promise of the Nav1.7 sodium channel as a pain target. Despite compelling genetic validation, drug developers are struggling to unlock the therapeutic promise of the Nav1.7 sodium channel as a pain target.

Cite

CITATION STYLE

APA

Kingwell, K. (2019). Nav1.7 withholds its pain potential. Nature Reviews Drug Discovery, 18(5), 321–323. https://doi.org/10.1038/d41573-019-00065-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free